BA vs BBIO · P/E 89, rev $89.46B vs rev $221.9M
The Boeing Company (BA) versus BridgeBio Pharma Inc (BBIO) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
BA currently screens at market cap $177.86B and trailing P/E 89.2. BBIO currently screens at market cap $13.24B.
Not investment advice. Open the BA and BBIO stock pages for the full models.
Not investment advice.